Pelizaeus-Merzbacher disease: A disorder of the
central nervous system (CNS) in which there is loss of
myelin, the sheath around the nerves. The disease is clinically characterized by
nystagmus (rhythmical oscillation of the eyes), impaired
motor development,
tremor,
progressive spasticity (increased muscle tone),
ataxia (wobbliness), choreoathetotic movements, and dysartria (difficulty speaking). Pelizaeus-Merzbacher disease (PMD) in its classical form manifests in infancy or early
childhood and progresses to severe spasticity and ataxia. The lifespan may be shortened.
PMD is due to
mutation in the
gene PLP1. This gene is located on the
X chromosome in band Xq22. The disease describes an
X-linked pattern of
inheritance with boys who have the mutation affected with the disease while females with the mutation are carriers.
The PLP1 gene encodes
proteolipid protein (
PLP), the most abundant
protein of the
myelin sheath in the
CNS. The mutation in PLP1 in PMD results in loss of myelin and that, in turn, causes the
neurological abnormalities.
The severity of myelin loss is dependent on the particular PLP1 mutation and can range from early
lethal forms of PMD to a mild disorder known as spastic
paraplegia type 2 (SPG2).
Among the mutations in the PLP1 gene
locus that can cause PMD is a
duplication of PLP1 in which the duplicated region may be far away from the original PLP locus in
chromosome region Xq22. The PLP1 duplication is almost always present in the mothers of affected boys and usually can be traced to the
maternal grandfather. The disease is named for the German
neurologist Friedrich Pelizaeus (1850-1917) and
psychiatrist Ludwig Merzbacher (1875-1942) who independently described the disorder in 1885 and 1909, respectively. The disease is a hypomyelinating X-linked
leukodystrophy.
MedTerms (TM) is the Medical Dictionary of
MedicineNet.com.
We Bring Doctors' Knowledge To You
Click on a letter to see a list of Medical Terms beginning with that letter. Each term links to a medical definition.